The aldB gene in L. lactis is clustered with BCAA biosynthesis genes (ilvBN) and exhibits dual transcriptional control:
BCAA-dependent regulation: Transcribed alongside ilvBN under isoleucine-mediated attenuation .
Independent regulation: Activated by its own promoter during catabolic acetolactate synthesis .
The enzyme catalyzes the decarboxylation of α-acetolactate to acetoin, a precursor for diacetyl (2,3-butanedione), and modulates acetolactate flux between biosynthesis and catabolism .
Recombinant aldB strains are engineered for:
Diacetyl production: Deletion of aldB redirects acetolactate to diacetyl via spontaneous decarboxylation .
Flavor enhancement: Overexpression of ilvBN in aldB-deleted strains amplifies acetolactate synthesis, boosting diacetyl yields .
Fermentation optimization: Engineered L. lactis strains achieve 80% pyruvate flux redirection to acetolactate, surpassing natural diacetylactis strains .
Biosensor integration: aldB-deficient strains enable real-time monitoring of diacetyl via GFP-based biosensors .
Gut microbiome modulation: Recombinant aldB-expressing L. lactis mitigates colitis by regulating pro-inflammatory cytokines (e.g., TNF-α, IFN-γ) .
KEGG: lla:L0321
STRING: 272623.L0321